Role of fertility-sparing surgery in gynecological malignancy

Abstract

Gynecological malignancy in reproductive age group is not uncommon. Around 12.5% of women with female genital tract malignancy are aged <45 years at the time of diagnosis.[1] Earlier, cancer treatment emphasized mainly on the survival outcome. But now, with the advent of newer chemotherapeutic agents, better surgical techniques, and newer treatment regimens, mortality rates are decreasing, and more emphasis can be given to improve the morbidity profile following cancer treatment. And, talking about morbidity, fertility preservation is one of the major concerns of young patients seeking cancer treatment.